Attrition in the drug discovery process: lessons to be learned from the safety pharmacology paradigm

被引：0
|
作者：
Curtis, Michael J. [1 ]
Pugsley, Michael K. [2 ]
机构：
[1] St Thomas Hosp, Kings Coll London, Rayne Inst, Div Cardiovasc, London SE1 7EH, England
[2] Janssen Res & Dev, Dept Toxicol & Pathol Drug Safety Sci, Raritan, NJ 08869 USA
来源：
EXPERT REVIEW OF CLINICAL PHARMACOLOGY | 2012年 / 5卷 / 03期
关键词：
academia; cardiac toxicity; discovery pharmacology; drug attrition; drug development costs; intellectual property; safety pharmacology; INNOVATION;
D O I：
10.1586/ECP.12.22
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：237 / 240
页数：4
相关论文
共 50 条
  • [41] Lessons learned from process incident databases and the process safety incident database (PSID) approach sponsored by the Center for Chemical Process Safety
    Sepeda, AL
    JOURNAL OF HAZARDOUS MATERIALS, 2006, 130 (1-2) : 9 - 14
  • [42] Drug discovery and development: lessons from an undeveloped drug
    Gordi, Toufigh
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2012, 5 (02) : 157 - 162
  • [43] Lessons learned from a process tank explosion
    Marwitz, SR
    Smith, RP
    Hamsayeh, R
    PROCESS INDUSTRY INCIDENTS: INVESTIGATION PROTOCOLS, CASE HISTORIES, LESSONS LEARNED, 2000, : 31 - 37
  • [44] Lessons Learned From a Consultation Process Overseas
    Merino-Soto, Cesar
    JOURNAL OF EDUCATIONAL AND PSYCHOLOGICAL CONSULTATION, 2014, 24 (04) : 340 - 344
  • [45] Addressing conflicts of interest in nanotechnology oversight: lessons learned from drug and pesticide safety testing
    Elliott, Kevin C.
    Volz, David C.
    JOURNAL OF NANOPARTICLE RESEARCH, 2012, 14 (01)
  • [46] Addressing conflicts of interest in nanotechnology oversight: lessons learned from drug and pesticide safety testing
    Kevin C. Elliott
    David C. Volz
    Journal of Nanoparticle Research, 2012, 14
  • [47] Lessons learned from the preclinical drug discovery of PRMs for non-surgical treatment of uterine fibroids
    Maruo, Takeshi
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 33 - 33
  • [48] Shifting the Paradigm from Lessons Learned to Lessons Applied through Digitally Enabled Transformation
    Wach, Paul
    Wittenberg, Donald
    Koziol, Matthew
    Sandman, Karson
    INCOSE International Symposium, 2023, 33 (01) : 197 - 211
  • [49] Lessons learned from HIV treatment interruption: Safety, correlates of immune control, and drug sparing
    Azzoni, L
    Papasavvas, E
    Montaner, LJ
    CURRENT HIV RESEARCH, 2003, 1 (03) : 329 - 342
  • [50] Using transcriptomics to guide lead optimization in drug discovery projects: Lessons learned from the QSTAR project
    Verbist, Bie
    Klambauer, Guenter
    Vervoort, Liesbet
    Talloen, Willem
    Shkedy, Ziv
    Thas, Olivier
    Bender, Andreas
    Goehlmann, Hinrich W. H.
    Hochreiter, Sepp
    DRUG DISCOVERY TODAY, 2015, 20 (05) : 505 - 513
12345